NANOBIOTIX (NANO.PA) Forecast, Price Target & Analyst Ratings
EPA:NANO • FR0011341205
28.65 EUR
-0.2 (-0.69%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NANOBIOTIX (NANO.PA).
Forecast Snapshot
Consensus Price Target
€23.32
-18.59% Downside
Next Earnings Forecast
Release DateMar 31, 2026
PeriodQ4 / 2025
EPS Estimate€0.56
Revenue Estimate59.821M
ChartMill Buy Consensus
85.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€23.32
Upside
-18.59%
From current price of €28.65 to mean target of €23.32, Based on 12 analyst forecasts
Low
€19.90
Median
€22.95
High
€29.40
Price Target Revisions
1 Month
0.37%
3 Months
21.31%
Price Target Summary
12 analysts have analysed NANO.PA and the average price target is 23.32 EUR. This implies a price decrease of -18.59% is expected in the next year compared to the current price of 28.65.
The average price target has been revised upward by 21.31% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
NANO.PA was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NANO.PA.
In the previous month the buy percentage consensus was at a similar level.
NANO.PA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 31, 2026
PeriodQ4 / 2025
EPS Estimate€0.56
Revenue Estimate59.821M
Revenue Q2Q462.99%
EPS Q2Q156.72%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
NANO.PA is expected to report earnings on 3/31/2026. The consensus EPS estimate for the next earnings is 0.56 EUR and the consensus revenue estimate is 59.82M EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 30.058M | -11.609M -138.62% | 46.869M 503.73% | 52.366M 11.73% | 52.117M -0.48% | 73.758M 41.52% | 57.26M -22.37% | 126.75M 121.36% | 282.97M 123.25% | 385.99M 36.41% | 614.92M 59.31% | |
| EBITDA YoY % growth | -45.202M 11.40% | -25.266M 44.10% | -66.771M -164.27% | -4.658M 93.02% | -24.761M -431.57% | 5.33M 121.53% | -41.605M -880.58% | -44.059M -5.90% | 171.76M 489.84% | 74.011M -56.91% | 112.08M 51.44% | N/A | |
| EBIT YoY % growth | -46.702M 11.18% | -26.779M 42.66% | -68.392M -155.39% | -3.124M 95.43% | -8.936M -186.07% | 510.612K 105.71% | 9.689M 1,797.53% | -12.294M -226.89% | 48.205M 492.10% | 161.7M 235.44% | 249.92M 54.56% | 462.73M 85.15% | |
| Operating Margin | N/A | -89.09% | 589.13% | -6.66% | -17.06% | 0.98% | 13.14% | -21.47% | 38.03% | 57.14% | 64.75% | 75.25% | |
| EPS YoY % growth | N/A -5.70% | -1.08 24.32% | -1.44 -33.33% | -0.31 78.75% | -0.76 -147.50% | -0.23 69.36% | -0.26 -11.74% | -0.18 29.54% | 1.67 1,015.52% | 2.24 34.13% | 2.71 20.98% | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.56 156.72% | -0.14 -29.82% | 1.01 81.65% |
| Revenue Q2Q % growth | 59.821M 462.99% | 24.378M -8.48% | 94.86M 58.57% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | 32.104M 171.76% | N/A | N/A |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
22.28%
EPS Next 5 Year
13.40%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
31.26%
Revenue Next 5 Year
19.60%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
28.42%
EBIT Next 5 Year
0.83%
NANOBIOTIX / NANO.PA Forecast FAQ
Can you provide the average price target for NANOBIOTIX stock?
12 analysts have analysed NANO.PA and the average price target is 23.32 EUR. This implies a price decrease of -18.59% is expected in the next year compared to the current price of 28.65.
What is the next earnings date for NANO stock?
NANOBIOTIX (NANO.PA) will report earnings on 2026-03-31, after the market close.
What are the consensus estimates for NANO stock next earnings?
The consensus EPS estimate for the next earnings of NANOBIOTIX (NANO.PA) is 0.56 EUR and the consensus revenue estimate is 59.82M EUR.
Can you provide the analyst count for NANOBIOTIX stock?
The number of analysts covering NANOBIOTIX (NANO.PA) is 12.